![Daniel Salain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Daniel Salain currently works at Recall Therapeutics, Inc., as President & Director and Aceragen, Inc. (North Carolina), as Chief Operating Officer from 2020.
Mr. Salain also formerly worked at Idera Pharmaceuticals, Inc., as Chief Operating Officer, Aptalis Pharma LLC, as Vice President-Global Supply Chain & Manufacturing from 1999 to 2014, Graybug Vision, Inc., as Chief Operations & Technology Officer from 2019 to 2020, IVERIC bio, Inc., as Senior Vice President-Technical Operations from 2015 to 2017, Eurand Pharmaceuticals, Inc., as Vice President-Operations, and Aceragen, Inc., as Chief Operating Officer from 2020 to 2023.
Mr. Salain received his undergraduate degree from the University of Indianapolis.
Postes actifs de Daniel Salain
| Sociétés | Poste | Début |
|---|---|---|
Aceragen, Inc. (North Carolina)
 Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutics for orphan diseases | Directeur des opérations | 01/06/2020 |
Anciens postes connus de Daniel Salain
| Sociétés | Poste | Fin |
|---|---|---|
| ACERAGEN, INC. | Directeur des opérations | 01/05/2023 |
| CALCIMEDICA, INC. | Directeur des opérations | 01/05/2020 |
| IVERIC BIO, INC. | Directeur Technique/Scientifique/R&D | 01/11/2017 |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology | Corporate Officer/Principal | 01/11/2014 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur des opérations | - |
Formation de Daniel Salain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
University of Indianapolis
 University of Indianapolis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Eurand Pharmaceuticals, Inc. | Health Technology |
Aceragen, Inc. (North Carolina)
Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutics for orphan diseases | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
